Cargando…

INHBA is a mediator of aggressive tumor behavior in HER2+ basal breast cancer

BACKGROUND: Resistance to HER2-targeted therapeutics remains a significant clinical problem in HER2+ breast cancer patients with advanced disease. This may be particularly true for HER2+ patients with basal subtype disease, as recent evidence suggests they receive limited benefit from standard of ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Moqing, Smith, Rebecca, Liby, Tiera, Chiotti, Kami, López, Claudia S., Korkola, James E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898494/ https://www.ncbi.nlm.nih.gov/pubmed/35248133 http://dx.doi.org/10.1186/s13058-022-01512-4

Ejemplares similares

Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease
por: Smith, Rebecca, et al.
Publicado: (2020)

Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes
por: Watson, Spencer S., et al.
Publicado: (2018)

Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CA
por: Garay, Joseph P., et al.
Publicado: (2021)

Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens
por: Nagaraja, Archana S., et al.
Publicado: (2021)

INHBA is a prognostic predictor for patients with colon adenocarcinoma
por: Li, Xueying, et al.
Publicado: (2020)

INHBA is a novel mediator regulating cellular senescence and immune evasion in colorectal cancer
por: Chen, Shuai, et al.
Publicado: (2021)

Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer
por: Yu, Zeying, et al.
Publicado: (2022)

DNA Hypomethylation Is Associated with the Overexpression of INHBA in Upper Tract Urothelial Carcinoma
por: Kao, Chien-Chang, et al.
Publicado: (2022)

Corrigendum: Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer
por: Yu, Zeying, et al.
Publicado: (2022)

Upregulation of INHBA mediated by the transcription factor BHLHE40 promotes colon cancer cell proliferation and migration
por: Wang, Jianan, et al.
Publicado: (2022)

INHBA upregulation correlates with poorer prognosis in patients with esophageal squamous cell carcinoma
por: Lyu, Shanshan, et al.
Publicado: (2018)

INHBA is a Prognostic Biomarker and Correlated With Immune Cell Infiltration in Cervical Cancer
por: Zhao, Kaidi, et al.
Publicado: (2022)

A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markers
por: Hamalian, Sarkis, et al.
Publicado: (2021)

INHBA promotes the proliferation, migration and invasion of colon cancer cells through the upregulation of VCAN
por: Guo, Jia, et al.
Publicado: (2021)

Identification of INHBA as a potential biomarker for gastric cancer through a comprehensive analysis
por: Liu, Fang, et al.
Publicado: (2023)

Impaired angiogenesis in diabetic critical limb ischemia is mediated by a miR-130b/INHBA signaling axis
por: Cheng, Henry S., et al.
Publicado: (2023)

Correlation of INHBA Overexpression with Pathological Features, Antitumor Immune Response and Clinical Prognosis in Cervical Cancer
por: Zeng, Lin, et al.
Publicado: (2023)

Preeclampsia-Associated lncRNA INHBA-AS1 Regulates the Proliferation, Invasion, and Migration of Placental Trophoblast Cells
por: Jiang, Sijia, et al.
Publicado: (2020)

Targeting INHBA in Ovarian Cancer Cells Suppresses Cancer Xenograft Growth by Attenuating Stromal Fibroblast Activation
por: Li, Xiaoting, et al.
Publicado: (2019)

Expression and gene regulation network of INHBA in Head and neck squamous cell carcinoma based on data mining
por: Wu, Zeng-hong, et al.
Publicado: (2019)

Aggressive behavior of Her-2 positive colloid breast carcinoma: A case report in a metastatic breast cancer
por: Anwar, Sumadi Lukman, et al.
Publicado: (2020)

Inhibin β-A (INHBA) induces epithelial–mesenchymal transition and accelerates the motility of breast cancer cells by activating the TGF-β signaling pathway
por: Yu, Yingying, et al.
Publicado: (2021)

A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancer
por: Miyamoto, Yuji, et al.
Publicado: (2020)

An immune-related model based on INHBA, JAG2 and CCL19 to predict the prognoses of colon cancer patients
por: Yang, Xuankun, et al.
Publicado: (2021)

The relationship between basal and acute HPA axis activity and aggressive behavior in adults
por: Böhnke, Robina, et al.
Publicado: (2010)

Cytokeratin 5/6 fingerprinting in HER2-positive tumors identifies a poor prognosis and trastuzumab-resistant Basal-HER2 subtype of breast cancer
por: Martin-Castillo, Begoña, et al.
Publicado: (2015)

M2‐phenotype tumour‐associated macrophages upregulate the expression of prognostic predictors MMP14 and INHBA in pancreatic cancer
por: Liang, Zhan‐Wen, et al.
Publicado: (2022)

Dysregulation of Npas4 and Inhba expression and an altered excitation–inhibition balance are associated with cognitive deficits in DBA/2 mice
por: Oberländer, Kristin, et al.
Publicado: (2022)

INHBA gene silencing inhibits proliferation, migration, and invasion of osteosarcoma cells by repressing TGF-β signaling pathway activation
por: Zhang, Hongyu, et al.
Publicado: (2023)

HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness
por: Pupa, Serenella M., et al.
Publicado: (2021)

Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer
por: Coleman, Daniel J., et al.
Publicado: (2019)

Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer
por: Castagnoli, L, et al.
Publicado: (2017)

Hunger Artists: Yeast Adapted to Carbon Limitation Show Trade-Offs under Carbon Sufficiency
por: Wenger, Jared W., et al.
Publicado: (2011)

Metformin suppresses the growth of colorectal cancer by targeting INHBA to inhibit TGF-β/PI3K/AKT signaling transduction
por: Xiao, Qing, et al.
Publicado: (2022)

RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer
por: Prokakis, Evangelos, et al.
Publicado: (2023)

Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice
por: Dupouy, Sandra, et al.
Publicado: (2014)

Cryosurgery of Periocular Moderately Aggressive Basal Cell Carcinoma
por: FINSKAS, Oscar, et al.
Publicado: (2020)

Anti-HER2/Neu passive-aggressive immunotherapy
por: Mortenson, Eric D, et al.
Publicado: (2014)

Tumor microbiome contributes to an aggressive phenotype in the basal-like subtype of pancreatic cancer
por: Guo, Wei, et al.
Publicado: (2021)

The RXR Agonist MSU42011 Is Effective for the Treatment of Preclinical HER2+ Breast Cancer and Kras-Driven Lung Cancer
por: Leal, Ana S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6oqp5h6c5asgdev3l5pminp0l5